Allergy Therapeutics (AGY) Stock Chart & Stock Price History GBX 8.25 +0.25 (+3.13%) As of 12:42 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Allergy Therapeutics Stock Price Performance The Allergy Therapeutics (AGY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 42.24%, with a year-to-date return of 26.44%. In the past month, the stock has increased 10.00%, reflecting recent market activity. As of the latest close, Allergy Therapeutics traded at GBX 8 with a market cap of £393.21 million and volume of 282,513 shares. Five years ago, the stock traded at GBX 14.75, representing a 44.07% decrease over that period. At the time, it had a market cap of £94 million and a volume of 1.69 million shares. Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance+10.00%3 Month Performance+44.74%Year-To-Date Performance+26.44%1 Year Performance+42.24%5 Year Performance-44.07% AGY Stock Chart for Wednesday, July, 16, 2025 AGY Chart by TradingView Allergy Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025GBX 8GBX 8GBX 8.20GBX 7.50282,513 shs£393.21 million07/14/2025GBX 8.25GBX 8-3.03%GBX 8.30GBX 7.60575,978 shs£393.21 million07/11/2025GBX 8.25GBX 8.25GBX 8.30GBX 7.86417,367 shs£405.49 million07/10/2025GBX 8GBX 8.25+3.13%GBX 8.25GBX 7.50179,228 shs£405.49 million07/09/2025GBX 8.10GBX 8-1.23%GBX 8.10GBX 7.50201,344 shs£393.21 million07/08/2025GBX 8GBX 8.10+1.25%GBX 8.10GBX 7.48260,751 shs£398.12 million07/07/2025GBX 8GBX 8GBX 8GBX 7.46306,831 shs£393.21 million07/04/2025GBX 8GBX 8GBX 8GBX 7.2575,178 shs£393.21 million07/03/2025GBX 8GBX 8GBX 8GBX 7.2575,178 shs£393.21 million07/02/2025GBX 8GBX 8GBX 8GBX 7.39150,467 shs£393.21 million Get the Latest News and Ratings for AGY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025GBX 7.95GBX 8+0.63%GBX 8GBX 7.25584,082 shs£393.21 million06/30/2025GBX 7.30GBX 7.95+8.90%GBX 7.95GBX 7.161.04 million shs£390.75 million06/27/2025GBX 7.30GBX 7.30GBX 7.50GBX 7.061.21 million shs£358.80 million06/26/2025GBX 7.70GBX 7.30-5.19%GBX 7.85GBX 7.031.50 million shs£358.80 million06/25/2025GBX 6.77GBX 7.70+13.79%GBX 7.70GBX 6.79386,719 shs£378.46 million06/24/2025GBX 7GBX 6.77-3.33%GBX 7.50GBX 6.501.13 million shs£332.60 million06/23/2025GBX 6.90GBX 7+1.45%GBX 7.50GBX 6.50297,610 shs£344.06 million06/20/2025GBX 6.90GBX 6.90GBX 7.35GBX 6.68294,361 shs£339.14 million06/19/2025GBX 7GBX 6.90-1.43%GBX 7.50GBX 6.68123,576 shs£339.14 million06/18/2025GBX 7.10GBX 7-1.41%GBX 7.14GBX 6.75761,218 shs£344.06 million06/17/2025GBX 7.50GBX 7.10-5.33%GBX 7.50GBX 6.70492,458 shs£348.97 million06/16/2025GBX 7.25GBX 7.50+3.45%GBX 7.50GBX 6.62140,300 shs£368.63 million Related Companies APH Stock Chart ANCR Stock Chart VLG Stock Chart EAH Stock Chart STX Stock Chart PXS Stock Chart CEL Stock Chart N4P Stock Chart HELD Stock Chart HLN Stock Chart Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AGY) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AGY Stock Alerts